Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery

General Physiology and Biophysics

Volumn 28, Issue SPECIAL ISSUES, 2009, Pages 262-270

  Jovic, Miomir ^a   Gradinac, Sinisa ^a   Lausevic Vuk, Ljiljana ^a   Nezic, Dusko ^a   Stevanovic, Predrag ^b   Milojevic, Predrag ^a   Djukanovic, Bosko ^a  

^a Dedinje Cardiovascular Institute   (Serbia)

^b Clinical Center Dr Dragisa Misovic   (Serbia)

Author keywords

Coronary surgery; GIK; Haemodynamic parameters; Oxygen profile

Indexed keywords

GLUCOSE; INOTROPIC AGENT; INSULIN; POTASSIUM; RINGER SOLUTION;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY SURGERY; CORONARY HEMODYNAMICS; DRUG MEGADOSE; FEMALE; HEART FUNCTION; HEART INDEX; HEART MUSCLE OXYGEN CONSUMPTION; HEART PROTECTION; HUMAN; ISCHEMIC PRECONDITIONING; LOW DRUG DOSE; MALE; OXYGEN SUPPLY; PULMONARY ARTERY OCCLUSION PRESSURE; RANDOMIZED CONTROLLED TRIAL;

CORONARY DISEASE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; FEMALE; GLUCOSE; HEART; HEMODYNAMICS; HUMANS; INSULIN; INTRAOPERATIVE PERIOD; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MIDDLE AGED; OXYGEN; POSTOPERATIVE PERIOD; POTASSIUM; RECOVERY OF FUNCTION; SOLUTIONS; THORACIC SURGERY;

EID: 77649243097     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Akao M., Ohler A., O'Rourke B., Marban E. (2001): Mitochondrial ATP-sensitive potassium channels inhibit apoptosis induced by oxidative stress in cardiac cells. Circ. Res. 88, 1267-1275
2. Bertrand L., Horman S., Beauloye C., Vanoverchelde L. J. (2008): Insulin signaling in the heart. Cardiovasc. Res. 79, 238-248
3. Bolli R., Jeroudi M. O., Patel B. S., Arouma I. O., Halliwell B., Lai K. E., McCay B. P. (1989): Marked reduction of free radical generation and contractile dysfunction by antioxidant therapy begun at the time of reperfusion: evidence that myocardial "stunning" is a manifestation of reperfusion injury. Circ. Res. 65, 607-622
4. Bolli R. (1990): Mechanism of myocardial "stunning". Circulation 82, 723-738
5. Boyd O., Grounds R. M., Bennett E. D. (1993): A randomized clinical trial of the effect of deliberate perioperative increase of oxygen delivery on mortality in high-risk surgical patients. JAMA 270, 2699-2707
6. Brix-Christiensen V., Andersen S. K., Andersen R., Mengel R., Dyhr T., Andersen N. T., Larsson A., Schmitz O., Orskov H., Tonnesen E. (2004): Acute hyperinsulinemia restrains endotoxine-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology 100, 861-870
7. Chai W., Wu Y., Li G., Cao W., Yang Z., Liu Z. (2008): Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemiareperfusion injury. Am. J. Physiol., Endocrinol. Metab. 294, E183-189
8. Diaz R., Paolasso A. E., Piegas S. L., Tajer D. C., Moreno G. M, Corvalan R., Isea E. J., Romero G. (1998): Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulin-potassium pilot trial. Circulation 98, 2227-2234
9. Downing S. E., Lee J. C., Rieker R. P. (1977): Mechanical and metabolic effects of insulin on newborn lamb myocardium. Am. J. Obstet. Gynecol. 127, 649-656
10. Elefteriadis J. A., Kron I. L. (1995): CABG in advanced left ventricular dysfunction. Cardiol. Clin. 13, 1036-1045
11. th edition), pp. 1161-1183, W. B. Saunders Company, Philadelphia
12. Girard C., Quentin P., Bouvier H., Blanc P., Bastien O., Lehot J. J., Mikealoff P., Estanove S. (1992): Glucose and insulin supply befor cardiopulmonary bypass in cardiac surgery: a double blind study. Ann. Thorac. Surg. 54, 259-263
13. Gradinac S., Coleman G. M., Taegtmeyer H., Sweeny M., Frazier H. O. (1989): Improved cardiac function with glucoseinsulin-potassium after aortocoronary bypass grafting. Ann. Thorac. Surg. 48, 484-489
14. Gross G. J., Auchampach J. A. (1992): Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ. Res. 70, 223-233
15. Hansen T. K., Thiel S., Wouters P. J., Christiansen J. S., Van den Berhe G. (2003): Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lecithin levels. J. Clin. Endocrinol. Metab. 88, 1082-1088
16. Kaul K. T., Agnihtory K. A., Fields L. B., Riggins S. L., Wyatt A. D., Jones R. C. (1996): Coronary artery bypass grafting in patients with ejection fraction of twenty percent or less. J. Cardiovasc. Surg. 5, 1001-1012
17. Kloner A. R., Nesto W. R. (2008): Glucose-insulin-potassium for acute myocardial infarction: continuing controversy over cardioprotection. Circulation 117, 2523-2533
18. Koskenkari K. J., Kaukoranta K. P., Rimpilainen J., Vainionpaa V., Ohtonen P. P., Surcel M. H. Juvonen T., Ala-Kokko I. T. (2006): Anti-inflammatory effect of high-dose insulin treatment after urgent coronary revascularization surgery. Acta Anaesthesiol. Scand. 50, 962-969
19. La Disa F. J., Krolikowski G. J., Pagel S. P., Warltier C. D., Kersten R. J. (2004): Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. Am. J. Physiol., Heart. Circ. Physiol. 287, H601-607
20. Laine H., Nuutila P., Loutalahti M., Meyer C., Elomaa T., Koskinene P., Ronnemaa T., Knuuti J. (2000): Insulin-induced increment of coronary flow reserve is not abolished by dexamethasone in healthy young men. J. Clin. Endocrinol. Metab. 85, 1868-1873
21. Lazar L. H., Philippides G., Fitzgerald C., Lancaster D., Shemin J. R., Apstein C. (1997): Glucose-insulin-potassium solutions enhance recovery after urgent coronary artery bypass grafting. J. Thorac. Cardiovasc. Surg. 113, 354-360
22. Malmberg K., Ryden L., Hamsten A., Herlitz J., Waldenstrom A., Wedel H. (1996): Effects of insulin treatment on causespecific one-year mortality and morbidity in diabetic patients with acute myocardial infarction. DIGAMI study group. Diabetes-insulin-glucose in acute myocardial infarction. Eur. Heart. J. 17, 1337-1344
23. Nesto W. R., Lago M. R. (2008): Glucose: a biomarker in acute myocardial infarction ready for prome time? Circulation 117, 990-992
24. Opie L. (1988): Hypothesis: glycolytic rates control cell viability in ischemia. J. Appl. Cardiol. 3, 407-414
25. Rasoul S., Ottervanger J. P., Timmer J. R., Svilaas T., Henriques J. P., Dambrink J. H., van der Horst I. C., Zijlstra F. ( 2007): One year outcomes after glucose-insulin-potassium in ST elevation myocardial infarction. The glucose-insulinpotassium study II. Int. J. Cardiol. 122, 52-55
26. Shoemaker W. C., Kram K. B., Appel P. L., Kram B. H., Waxman K., Lee S. T.(1988): Prospective trial of supranormal values of survivors as therapeutic goals in high-risk surgical patients. Chest 94, 1176-1188
27. Shoemaker W. C., Appel P. L., Kram H. B. (1992a): Role of oxygen debt in the development of organ failure, sepsis, and death in high-risk surgical patients. Chest 102, 208-215
28. Shoemaker W. C., Patil R., Appel P. L., Kram H. B. (1992b): Hemodynamic and oxygen transport patterns for outcome prediction, therapeutic goals, and clinical algorithms to improve outcome. Feasibility of artificial intelligence to customize algorithms. Chest 102, 617-625
29. Sodi-Pallares D., Testelli M., Fishleder F. (1962): Effects of an intravenous infusion of a potassium-insulin-glucose solution on the electrocardiographic signs of myocardial infarction. Am. J. Cardiol. 9, 166-181
30. Svedjeholm R., Hallhagen S., Ekroth R., Joachimsson P. O., Ronquist G. (1991): Dopamine and high-dose insulin infusion (glucose-insulin-potassium) after a cardiac operation: effects on myocardial metabolism. Ann. Thorac. Surg. 51, 262-270
31. Szabó Z., Arnqvist H., Håkanson E., Jorfeldt L., Svedjeholm R. (2001): Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes. Clin. Sci. 101, 37-43
32. Tricarico D., Mallamaci R., Barbieri M., Conte Camerini D. (1997): Modulation of ATP-sensitive K+ channels by insulin in rat skeletal muscle fibers. Biochem. Biophys. Res. Commun. 232, 536-539
33. Trachiotis D. G., Weintraub S. W., Johnston S. T., Jones L. E., Guyton A. R., Craver M. J. (1998): Coronary artery by pass grafting in patients with advanced left ventricular dysfunction. Ann. Thorac. Surg. 66, 1632-1639
34. Tsang W. M., Davidoff R., Korach A., Apstein S. C., Hesselvik F. J., Nguyen H., Shemin J. R., Shapita M. O. (2007): Diastolic dysfunction after coronary artery bypass grafting-the effect of glucose-insulin-potassium infusion. J. Card. Surg. 22, 185-191
35. van der Horst I. C. C., Zijlstra F., van't Hof A. W. J., Doggen C. J. M., de Boer M.-J., Suryapranata H., Hoorntje J. C. A., Dambrink J.-H. E., Gaus R. O. B., Bilo H. J. G. (2003): Glucose-insulin-potassium infusion in patients treated with primary angioplasty for acute myocardial infarction. J. Am. Coll. Cardiol. 42, 784-791
36. van Wezel B. H. (2006): Glucose-insulin-potassium techniques in cardiac surgery: historical overview and future perspectives. Semin. Cardiothorac. Vasc. Anesth. 10, 224-227
37. Yetkin E., Senen K., Ileri M., Atak R., Yetkin O., Tandogan I., Turhan H., Cehreli S. (2002): Comparison of low-dose dobutamine stress echocardiography during glucoseinsulin-potassium infusion for detection of myocardial viability after anterior myocardial infarction. Coron. Artery Dis. 13, 145-149